Biologic therapy in primary systemic vasculitis of the young

---

Eleftheriou D., Melo M., Marks S. D., Tullus K., Sills J., Cleary G., ...More

RHEUMATOLOGY, vol.48, no.8, pp.978-986, 2009 (SCI-Expanded, Scopus)

• Publication Type: Article / Article
• Volume: 48 Issue: 8
• Publication Date: 2009
• Doi Number: 10.1093/rheumatology/kep148
• Journal Name: RHEUMATOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.978-986
• Open Archive Collection: AVESIS Open Access Collection
• Hacettepe University Affiliated: Yes

Abstract

Methods. This was a retrospective descriptive case series of children with PSV treated with biologic therapy between February 2002 and November 2007. Primary retrospective outcome assessment measures were: daily corticosteroid dose; Birmingham Vasculitis Activity Score (BVAS); and adverse events (including infection rate).